« Back to News

ionLUX™ High Bay installation by Ceravision among top ten inspirational warehouse designs

When it comes to lighting a warehouse, low energy schemes are always key. This can be achieved through different means such as installing control systems and by utilizing daylight.

Among the top ten inspirational lighting designs for warehouses that put limiting energy consumption at their centre, is the ionLUX™ High Bay installation by Ceravision at the warehouse of contact lens manufacturers CooperVision.

For more information on the lighting system installed at CooperVision, please click here.

To read the full article from the independent lighting gurus at LUX, please click here.

Further Information

Future Applications

Energy efficiency is a global driver within many markets and Ceravision’s core technology has the ability to address these markets. Due to the flexible nature of the technology we are able to facilitate a variety of power levels (400 W to 5 kW) and spectra ranging from visible to UV light.


Ceravision’s High Efficiency Plasma (HEP) light is particularly suited to medium and high power applications. The light is emitted from a very small source, which enables Ceravision to accurately focus and distribute the light. This in turn facilitates significantly greater optical performance.

Intellectual Property

Ceravision maintains an extensive Intellectual Property (“IP”) portfolio comprising Patents, Trade Marks and Design Rights.

Featured News

The testing of Ceravision’s High Efficiency Plasma (HEP) lamps in Rothamsted has been underway now for four months. The testing compares Ceravision’s HEP lamps with legacy metal halide lamps and new LED systems and their impact upon the growth of wheat.


Ceravision are delighted to announce the much anticipated debut of ionGROW, the world's first High Efficiency Plasma grow light, at the upcoming infoAgro exhibition taking place from the 10th - 12th May in Almeria, Spain.


Ceravision's Horticultural Growth Light Solution ionGROW™ is set to begin trials at Rothamsted Research.